Development Level

Tchem 2 | 1,890
Tclin 1 | 602

Disease

Cancer 3 | 2,346
Liver disease 3 | 219
osteosarcoma 3 | 7,933
Cholestasis 2 | 93
Chronic Obstructive Airway Disease 2 | 47
Colorectal Neoplasms 2 | 217
Coronary artery disease 2 | 240
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Hepatitis C 2 | 90
Human immunodeficiency virus infectious disease 2 | 92
Hypertension 2 | 287
Kidney disease 2 | 396
Liver Cirrhosis, Experimental 2 | 108
Lung Neoplasms 2 | 171
Prostatic Neoplasms 2 | 471
Schizophrenia 2 | 501
Squamous cell carcinoma 2 | 94
astrocytic glioma 2 | 2,241
diabetes mellitus 2 | 1,663
ependymoma 2 | 2,514
medulloblastoma, large-cell 2 | 6,234
psoriasis 2 | 6,685
tuberculosis 2 | 1,557
Acute Lung Injury 1 | 18
Acute kidney injury 1 | 65
Adenocarcinoma 1 | 115
Adverse reaction to drug 1 | 54
Aortic aneurysm 1 | 34
Aortic valve insufficiency 1 | 22
Atrophic 1 | 10
Autoimmune hepatitis 1 | 13
Autoimmune polyendocrine syndrome 1 | 6
Berylliosis 1 | 16
Camurati-Engelmann disease 1 | 5
Carcinosarcoma 1 | 6
Cardiovascular system disease 1 | 194
Chronic fatigue syndrome 1 | 29
Cleft palate 1 | 125
Colorectal Cancer 1 | 47
Common cold 1 | 63
Copper-Overload Cirrhosis 1 | 11
Corneal disease 1 | 32
Diabetes Mellitus, Experimental 1 | 106
Diabetic Nephropathy 1 | 37
Diabetic Neuropathies 1 | 13
Diabetic Retinopathy 1 | 53
Diaphragmatic Hernia 1 | 40
Diarrhea 1 | 155
Duodenal ulcer 1 | 20
Exanthem 1 | 39
Fibrosis 1 | 40
Growth Disorders 1 | 33
Hepatitis, Chronic 1 | 22
Hepatomegaly 1 | 10
Hereditary hemorrhagic telangiectasia 1 | 14
Hyperglycemia 1 | 120
Inflammation 1 | 109
Intervertebral Disc Degeneration 1 | 5
Kidney Diseases 1 | 86
Kidney Failure, Chronic 1 | 45
Leber congenital amaurosis 1 | 72
Liver Cirrhosis 1 | 101
Liver Neoplasms, Experimental 1 | 48
Liver diseases 1 | 66
Loeys-Dietz syndrome 1 | 23
Lung Injury 1 | 20
Lung diseases 1 | 48
Mammary Neoplasms 1 | 410
Marfan Syndrome 1 | 14
Methemoglobinemia 1 | 17
Migraine Disorders 1 | 26
Myocardial Infarction 1 | 126
Neoplasm Invasiveness 1 | 127
Neoplasm Metastasis 1 | 138
Neoplastic Cell Transformation 1 | 81
Nephrotic Syndrome 1 | 48
Neural Tube Defects 1 | 27
Neutropenia 1 | 78
Non-alcoholic Fatty Liver Disease 1 | 40
Oral Submucous Fibrosis 1 | 18
Osteoporosis 1 | 257
Pain agnosia 1 | 99
Pancreatitis 1 | 97
Papilloma 1 | 27
Periodontal disease 1 | 37
Peyronie's disease 1 | 8
Pneumonia 1 | 133
Portal hypertension 1 | 21
Pulmonary Fibrosis 1 | 66
Pulmonary emphysema 1 | 34
Retinal detachment 1 | 33
Schistosomiasis 1 | 38
Sepsis 1 | 21
Skin Neoplasms 1 | 49
Thrombocythemia, Essential 1 | 12
Torsades de Pointes 1 | 5
Uremia 1 | 19
Ureteral disease 1 | 23
Ureteral obstruction 1 | 6
sarcoidosis 1 | 358

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 2 | 11,971
Enzyme 1 | 4,146

Grant Application

5R01AA012852-04 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Transforming growth factor beta-1 TGFB1 Tchem Non-IDG -4.32707 20956.6 961
Cytochrome P450 3A4 CYP3A4 Tclin Enzyme -3.62253 4494.0 323
Cytochrome P450 1A2 CYP1A2 Tchem Non-IDG -3.30248 2022.5 420